Treatment of Congenital Nasolacrimal Duct Obstruction Via Intubation

Monocanalicular Masterka intubation versus pushed monaka intubation for treatment of congenital nasolacrimal duct obstruction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201208074580N2

Enrollment

Registered

2012-08-26

Start date

2012-04-08

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital obstruction or stenosis of nasolacrimal duct. Stenosis and insufficiency of lacrimal passages

Interventions

For Monaka group: children will undergo Monocanalicular Monaka intubation to treat congenital nasolacrimal duct obstruction.

Intervention 1: For Masterka group: children will undergo Monocanalicular Masterka intubation to treat congenital nasolacrimal duct obstruction. Intervention 2: For Monaka group: children will undergo

Treatment - Surgery

For Masterka group: children will undergo Monocanalicular Masterka intubation to treat congenital nasolacrimal duct obstruction.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: to have congenital nasolacrimal duct obstruction; to have a history of failed probing in any age; to be 2-7 years old without a history of prior probing. Exclusion criteria: to have a history of prior surgery on nasolacrmal system such as intubation and DCR; patients with Down syndrome; to have a proximal nasolacrimal duct anomaly; to have a history of trauma to nasolacrimal system; craniofacial abnormality.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Abcense of epiphora. Timepoint: 6 weeks after the stent removal. Method of measurement: DDT test.	—

Secondary

Measure	Time frame
Surgery complication. Timepoint: 6 weeks after the stent removal. Method of measurement: Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Mansoori

Tabriz University of Medical Sciences

hosseinmnsoorimed@yahoo.com+98 41 1657 7330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026